Silvant Capital Management LLC Grows Position in Mettler-Toledo International, Inc. $MTD

Silvant Capital Management LLC boosted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTDFree Report) by 26.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,874 shares of the medical instruments supplier’s stock after acquiring an additional 609 shares during the quarter. Silvant Capital Management LLC’s holdings in Mettler-Toledo International were worth $4,007,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of MTD. Geneos Wealth Management Inc. boosted its holdings in Mettler-Toledo International by 83.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 30 shares during the period. Baird Financial Group Inc. lifted its stake in Mettler-Toledo International by 3.1% during the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after purchasing an additional 40 shares during the last quarter. Jump Financial LLC lifted its stake in Mettler-Toledo International by 44.6% in the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after buying an additional 125 shares during the last quarter. Cerity Partners LLC lifted its stake in Mettler-Toledo International by 10.8% in the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after buying an additional 392 shares during the last quarter. Finally, AXA S.A. lifted its stake in Mettler-Toledo International by 2.9% in the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock valued at $5,433,000 after buying an additional 131 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on MTD shares. Robert W. Baird dropped their target price on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Stifel Nicolaus decreased their target price on Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a research report on Monday, May 18th. Wolfe Research initiated coverage on Mettler-Toledo International in a research report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Jefferies Financial Group upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and increased their target price for the stock from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Finally, Wall Street Zen downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Six investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $1,408.55.

Read Our Latest Stock Analysis on MTD

Mettler-Toledo International Stock Up 2.0%

MTD opened at $1,154.42 on Tuesday. The firm has a market capitalization of $23.33 billion, a P/E ratio of 27.07, a P/E/G ratio of 2.36 and a beta of 1.27. The firm’s 50 day moving average is $1,201.73 and its 200-day moving average is $1,310.13. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. The company had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The business’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the firm posted $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Equities analysts expect that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Read More

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.